Linear IgA bullous dermatosis (LABD) is an autoimmune disease that causes blisters. People with LABD can develop blisters in the skin and the mucous membranes in their mouth, genitals, and eyelids.

Amid political grandstanding and valuation concerns, among other factors, the once high-flying healthcare sector has swiftly reversed course for the worse in recent weeks. The pain has been especially ...

The Direxion Daily S&P Biotech Bear 3X Shares ETF offers -3X daily leverage to the S&P Biotechnology Select Industry Index, primarily attracting short-term traders. LABD has lost 99.98% of its value ...

Actually, there are several warning signs for biotechnology bulls, but the focus here is on the Direxion Daily S&P Biotech Bear 3X Shares LABD. The newly minted Direxion Daily S&P Biotech Bear 3X ...

Direxion Daily S&P Biotech Bear 3X Shares ETF failed to generate decent yield & price growth over the past 90 months. I don’t foresee this fund generating positive growth in the near future, either.

Over the past 12 months, LABD has changed by -80.98%, with its 52-week range spanning from 12.47 to 101.00. What Is the Daily Trading Range for LABD? The daily trading range for LABD has fluctuated ...

Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the Direxion Daily S&P Biotech Bear 3X Shares, where 4,050,000 ...

The Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA: LABU) and Direxion Daily S&P Biotech Bear 3X Shares (NYSEARCA: LABD) ETFs have their place in a trading strategy. They can even be used as very ...

After a third-quarter swoon that saw the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) and the SPDR S&P Biotech ETF (NYSE: XBI), two of the largest biotech exchange traded funds by assets, tumble ...

Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the ProShares UltraShort S&P500 ( SDS), which added 13,950,000 units, or ...